A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease - PubMed (original) (raw)
A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease
K Hensley et al. Proc Natl Acad Sci U S A. 1994.
Abstract
beta-Amyloid is a 39- to 43-amino-acid neurotoxic peptide that aggregates to form the core of Alzheimer disease-associated senile (amyloid) plaques. No satisfactory hypothesis has yet been proposed to explain the mechanism of beta-amyloid aggregation and toxicity. We present mass spectrometric and electron paramagnetic resonance spin trapping evidence that beta-amyloid, in aqueous solution, fragments and generates free radical peptides. beta-Amyloid fragments, at concentrations that previously have been shown to be neurotoxic to cultured neurons, can inactivate oxidation-sensitive glutamine synthetase and creatine kinase enzymes. Also, salicylate hydroxylation assays indicate that reactive oxygen species are generated by the beta-amyloid-(25-35) fragment during cell-free incubation. These results are formulated into a free radical-based unifying hypothesis for neurotoxicity of beta-amyloid and are discussed with reference to membrane molecular alterations in Alzheimer disease.
Similar articles
- A beta (25-35) peptide displays H2O2-like reactivity towards aqueous Fe2+, nitroxide spin probes, and synaptosomal membrane proteins.
Butterfield DA, Martin L, Carney JM, Hensley K. Butterfield DA, et al. Life Sci. 1996;58(3):217-28. doi: 10.1016/0024-3205(95)02279-1. Life Sci. 1996. PMID: 9499162 - Role of spermine in amyloid beta-peptide-associated free radical-induced neurotoxicity.
Yatin SM, Yatin M, Varadarajan S, Ain KB, Butterfield DA. Yatin SM, et al. J Neurosci Res. 2001 Mar 1;63(5):395-401. doi: 10.1002/1097-4547(20010301)63:5<395::AID-JNR1034>3.0.CO;2-Q. J Neurosci Res. 2001. PMID: 11223914 - The toxic conformation of the 42-residue amyloid beta peptide and its relevance to oxidative stress in Alzheimer's disease.
Irie K, Murakami K, Masuda Y, Morimoto A, Ohigashi H, Hara H, Ohashi R, Takegoshi K, Fukuda H, Nagao M, Shimizu T, Shirasawa T. Irie K, et al. Mini Rev Med Chem. 2007 Oct;7(10):1001-8. doi: 10.2174/138955707782110187. Mini Rev Med Chem. 2007. PMID: 17979802 Review. - Structural studies of amyloid-β peptides: Unlocking the mechanism of aggregation and the associated toxicity.
Aleksis R, Oleskovs F, Jaudzems K, Pahnke J, Biverstål H. Aleksis R, et al. Biochimie. 2017 Sep;140:176-192. doi: 10.1016/j.biochi.2017.07.011. Epub 2017 Jul 25. Biochimie. 2017. PMID: 28751216 Review.
Cited by
- Effect of the aggregation state of amyloid-beta (25-35) on the brain oxidative stress in vivo.
Kozina A, Herbert-Alonso G, Díaz A, Flores G, Guevara J. Kozina A, et al. PLoS One. 2024 Oct 29;19(10):e0310258. doi: 10.1371/journal.pone.0310258. eCollection 2024. PLoS One. 2024. PMID: 39471144 Free PMC article. - The Dual Role of Amyloid Beta-Peptide in Oxidative Stress and Inflammation: Unveiling Their Connections in Alzheimer's Disease Etiopathology.
Fanlo-Ucar H, Picón-Pagès P, Herrera-Fernández V, Ill-Raga G, Muñoz FJ. Fanlo-Ucar H, et al. Antioxidants (Basel). 2024 Oct 8;13(10):1208. doi: 10.3390/antiox13101208. Antioxidants (Basel). 2024. PMID: 39456461 Free PMC article. Review. - Quantitative 3D histochemistry reveals region-specific amyloid-β reduction by the antidiabetic drug netoglitazone.
Catto F, Dadgar-Kiani E, Kirschenbaum D, Economides A, Reuss AM, Trevisan C, Caredio D, Mirzet D, Frick L, Weber-Stadlbauer U, Litvinov S, Koumoutsakos P, Hyung Lee J, Aguzzi A. Catto F, et al. bioRxiv [Preprint]. 2024 Aug 17:2024.08.15.608042. doi: 10.1101/2024.08.15.608042. bioRxiv. 2024. PMID: 39185170 Free PMC article. Preprint. - Influence of Bilberry Extract on Neuronal Cell Toxicity.
König S, Bakuradze T, Jesser S, Sreeja HA, Carlsson MJ, Fahrer J, Kins S, Richling E. König S, et al. Biology (Basel). 2024 May 25;13(6):376. doi: 10.3390/biology13060376. Biology (Basel). 2024. PMID: 38927256 Free PMC article. - Aβ42 and ROS dual-targeted multifunctional nanocomposite for combination therapy of Alzheimer's disease.
Zhang L, Cao K, Xie J, Liang X, Gong H, Luo Q, Luo H. Zhang L, et al. J Nanobiotechnology. 2024 May 23;22(1):278. doi: 10.1186/s12951-024-02543-z. J Nanobiotechnology. 2024. PMID: 38783363 Free PMC article.
References
- Trends Neurosci. 1993 Oct;16(10):409-14 - PubMed
- Brain Res. 1993 Sep 3;621(1):35-49 - PubMed
- J Neurol Sci. 1980 Mar;45(2-3):323-30 - PubMed
- J Biol Chem. 1983 Oct 10;258(19):11823-7 - PubMed
- J Free Radic Biol Med. 1986;2(1):13-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical